Table 2.
Drug name | No. of patients | No. of patients reporting at least one suspected ADR (%) |
---|---|---|
ALU | 761 | 174 (22.9) |
ASAQ | 11 | 2 (18.2) |
DHAPQ | 3 | 0 (0) |
Others | 7 | 0 (0) |
Total | 782 | 176 (22.5) |
ADRs adverse drug reactions, ALU artemether/lumefantrine, ASAQ artesunate/amodiaquine, DHAPQ dihydroartemisinin/piperaquine